Contributory factors and patient harm including deaths associated direct acting oral anticoagulants (DOACs) medication incidents: evaluation of real world data reported to the national reporting and learning system.
Abdulrhman Al RowilyZahraa JalalVibhu PaudyalPublished in: Expert opinion on drug safety (2023)
= 13776; 87.58) including duplication of anticoagulant therapies, patients being discharged without DOACs, non-consideration of renal function and lack of commencement of DOACs post-surgery suggesting preventability of such reported incidents. This study shows that medication incidents involving DOACs hence have the potential to cause severe harm and deaths and there is a need to promote guideline adherence through education, training and decision support technologies.
Keyphrases
- direct oral anticoagulants
- patient safety
- adverse drug
- atrial fibrillation
- quality improvement
- oral anticoagulants
- venous thromboembolism
- healthcare
- end stage renal disease
- newly diagnosed
- minimally invasive
- electronic health record
- chronic kidney disease
- early onset
- peritoneal dialysis
- prognostic factors
- insulin resistance
- risk assessment
- skeletal muscle
- type diabetes
- climate change
- human health
- data analysis